An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.

Nathan Cole always wanted to serve his fellow Marines. Now, as one of those rare individuals diagnosed with ALS in his 30s, he is taking on a new role to support them.
News at USA Health
Stay up to date on the latest news from our providers, facilities and researchers at USA Health.

In an effort to understand the causes of disproportionate breast cancer outcomes in women, researchers at the University of South Alabama College of Medicine will explore whether and how socioeconomic difficulties affect human biology, leading to a higher cancer risk.
Luis del Pozo-Yauner, M.D., Ph.D., has devoted his professional life to the scientific research of amyloid light-chain (AL) amyloidosis, a disease that occurs when the bone marrow produces abnormal antibodies.

Silas Leavesley, Ph.D., professor of chemical and bimolecular engineering at the University of South Alabama, and Thomas Rich, Ph.D., professor of pharmacology at the USA College of Medicine, recently received the 2019 USA Center for Lung Biology Murray Bander Faculty Development Award. The award – which is given to one or two investigators each year— seeks to foster innovative discoveries in pulmonary research and promote faculty development.

The University of South Alabama College of Medicine’s Summer Research Program culminated with the 46th annual Medical Student Research Day that took place on July 26, 2019, in the Medical Sciences Building.

USA Health is the first and only healthcare system on the Gulf Coast with the technology to identify organisms that cause diseases – more commonly known as pathogens – in as little as 40 seconds.

Having a strong family support system is vital to the survival of newborns, especially when they are born too soon.

New research studies by physician-scientists at USA Health Mitchell Cancer Institute have been published online in advance of the 55th Annual Meeting of the American Society of Clinical Oncology.

Langford Webb, who had never had any suspicious spots or moles, first noticed a knot under his arm while bathing two years ago.

Luciana Madeira da Silva, Ph.D., a researcher at USA Health Mitchell Cancer Institute, has received a 2019 Minority and Minority-serving Institution Faculty Scholar in Cancer Research Award.

Two new classes of anti-cancer compounds discovered by scientists at USA Health Mitchell Cancer Institute show promise for the treatment or prevention of cancer, researchers told scientists convened for the recent annual meeting of the American Association for Cancer Research in Atlanta.

African-American patients with advanced ovarian cancer were found to have a pre-existing immune response linked to worse survival rates compared with their white counterparts, according to research led by Dr. Rodney P. Rocconi, a gynecologic oncologist and interim director of the USA Health Mitchell Cancer Institute.